Results 21 to 30 of about 2,789 (159)
Акушерство, гинекология и репродукция, 2022 Surgical and natural menopause is often associated with depression symptoms. Along with the postpartum period, perimenopause is a “window of vulnerability” for depression development, because decline in estrogen level accounts for extinction of ...
D. V. Blinov +8 more
doaj +1 more source
Royal jelly for genitourinary syndrome of menopause: A randomized controlled trial
Gynecology and Obstetrics Clinical Medicine, 2021 Objective: Genitourinary syndrome of menopause is a progressive condition characterized by a decrease in estrogen, which causes bothersome genital symptoms. The purpose of the study was to determine the effect of royal jelly on the genitourinary syndrome
Vahid Mehrnoush, Fatemeh Darsareh
doaj +1 more source
Genitourinary syndrome of menopause: a modern approach to treatment
Гинекология, 2020 Life expectancy over the past half century has increased significantly and by 2025 approximately one in six people on Earth will be over 60 years old, thus, age-related diseases become even more relevant, this also applies to menopausal syndrome in ...
Madina I. Mazitova, Rezeda R. Mardieva
doaj +1 more source
Revitalizing research in genitourinary syndrome of menopause [PDF]
American Journal of Obstetrics and Gynecology, 2019 Genitourinary syndrome of menopause is defined as the collection of signs and symptoms of the genitourinary tract from menopause, previously known as vulvovaginal atrophy. The Food and Drug Administration has approved select hormonal and nonhormonal treatment for vaginal atrophy, including systemic estrogen, vaginal estrogen, estrogen receptor ...
Olivia H. Chang, Marie Fidela R. Paraiso
openaire +4 more sources
Frontiers in Reproductive Health, 2021 Genitourinary syndrome of menopause (GSM) is a term used to define a compilation of signs and symptoms arising from decreased estrogenic stimulation of the vulvovaginal and lower urinary tract.
Ayane Cristine Alves Sarmento +7 more
doaj +1 more source
BMC Cancer, 2023 Background Vaginal CO2 laser therapy is a new treatment option for genitourinary syndrome of menopause. Its potential is particularly interesting in breast cancer survivors, where existing treatment options often are insufficient as hormonal treatment is
Sine Jacobsen +4 more
doaj +1 more source
Genitourinary syndrome of menopause: optimization of therapyfor vaginal symptoms [PDF]
Гинекология, 2018 The aim of the study was to investigate the dynamics of atrophic changes оn the use of low-dose regimens of local therapy with a druge containing only estriol and a druge containing estriol, progesterone and a culture of lactobacilli in patients with ...
E G Eprikyan +3 more
doaj +1 more source
Efficacy of Fractional Laser on Steroid Receptors in GSM Patients
Bioengineering, 2023 Background: To compare the efficacy of CO2 fractional laser with that of topical estriol for treating genitourinary syndrome of menopause and to investigate the relationship between epithelial thickness and vaginal atrophy.
Stella Catunda Pinho +9 more
doaj +1 more source
The controversies regarding the role of estrogens in urogynecology.
Folia Histochemica et Cytobiologica, 2008 Estrogens are crucial for the proper functioning of genitourinary tract. Hypoestrogenism related to menopause could be linked to numerous disturbances of lower urinary tract.
Tomasz Rechberger, Pawel Skorupski
doaj +3 more sources
ESTRIOL IN THERAPY OF VARIOUS GYNECOLOGICAL DISEASES
Медицинский совет, 2017 Estriol is an effective and safe drug to treat climacteric syndrome, genitourinary syndrome, in a complex therapy of genital organs prolapsed, atrophic processes at the menopause stage, hypoestrogenia, at cervical factor of infertility.
V. N. Prilepskaya, E. G. Nazarenko
doaj +1 more source